Barclays
CAI

Barclays’s Caris Life Sciences CAI Stock Holding History

Barclays’s Portfolio CAI Stock Details CAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.33M Buy
74,423
+20,306
+38% +$444K ﹤0.01% 2578
2025
Q4 		$1.46M Buy
54,117
+50,940
+1,603% +$1.43M ﹤0.01% 3161
2025
Q3 		$96.1K Sell
3,177
-6,823
-68% -$218K ﹤0.01% 4627
2025
Q2 		$267K Buy
+10,000
New +$270K ﹤0.01% 4105

Other funds holding CAI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JHWEPV
J. H. Whitney Equity Partners VI New Canaan, Connecticut $201M AUM
SSP
Sixth Street Partners Dallas, Texas $711M AUM 9.3% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Barclays's CAI Position: Q1 2026 in Review

Barclays increased its Caris Life Sciences (CAI) stake by 38% in Q1 2026, buying an estimated $444K and bringing the position to 74,423 shares worth $1.33M. The position accounts for ﹤0.01% of the portfolio, ranked #2578.

Barclays first reported a position in CAI in Q2 2025 and has held it in 4 quarters since. The position peaked at $1.46M in Q4 2025. 202 funds tracked by Wall St. Rank hold CAI as of Q1 2026.

  • Barclays held 74,423 shares of Caris Life Sciences worth $1.33M as of Q1 2026.
  • Barclays bought 20,306 Caris Life Sciences shares in Q1 2026, an estimated $444K.
  • Caris Life Sciences made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #2578 holding.
  • Barclays first reported a position in Caris Life Sciences in Q2 2025 and has held it in 4 quarters since.
  • Barclays's Caris Life Sciences position peaked at $1.46M in Q4 2025.
  • 202 funds tracked by Wall St. Rank held Caris Life Sciences as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.